_id
69105cd1ccc777a4e85d587f
Ticker
DRIO
Name
DarioHealth Corp
Exchange
NASDAQ
Address
322 W 57th Street, New York, NY, United States, 10019
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.dariohealth.com
Description
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Last Close
12.76
Volume
8303
Current Price
11.89
Change
-6.818181818181812
Last Updated
2025-11-29T12:22:28.624Z
Image
data:image/webp;base64,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
Ipo Date
2014-10-06T00:00:00.000Z
Market Cap
80812128
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7556666666666666
Sentiment Sources
3
Rating
4.5
Target Price
18.25
Strong Buy
3
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
5007000
Cost Of Revenue
1992000
Gross Profit
3015000
Operating Expenses
12499000
Operating Income
-9484000
Interest Expense
1186000
Pretax Income
-10466000
Net Income
-2076752
Eps
-0.04184389059334731
Dividends Per Share
-
Shares Outstanding
6768184
Income Tax Expense
-
EBITDA
-8733000
Operating Margin
-189.41481925304572
Total Other Income Expense Net
-982000
Cash
32128999
Short Term Investments
0
Receivables
2375000
Inventories
4869000
Total Current Assets
42185000
Property Plant Equipment
1324000
Total Assets
117727000
Payables
3469000
Short Term Debt
442000
Long Term Debt
30617000
Total Liabilities
42793000
Equity
74934000
Depreciation
547000
Change In Working Capital
-495000
Cash From Operations
-7350000
Capital Expenditures
41000
Cash From Investing
-41000
Cash From Financing
17393000
Net Change In Cash
9956999
PE
-
PB
7.875089860543946
ROE
-2.771441535217658
ROA
-1.7640405344568364
FCF
-7391000
Fcf Percent
-1.4761334132214898
Piotroski FScore
0
Health Score
22
Deep Value Investing Score
4
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
5007000
Quarters > 0 > income Statement > cost Of Revenue
1992000
Quarters > 0 > income Statement > gross Profit
3015000
Quarters > 0 > income Statement > operating Expenses
12499000
Quarters > 0 > income Statement > operating Income
-9484000
Quarters > 0 > income Statement > interest Expense
1186000
Quarters > 0 > income Statement > pretax Income
-10466000
Quarters > 0 > income Statement > net Income
-2076752
Quarters > 0 > income Statement > eps
-0.04184389059334731
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
49630949
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-8733000
Quarters > 0 > income Statement > operating Margin
-189.41481925304572
Quarters > 0 > income Statement > total Other Income Expense Net
-982000
Quarters > 0 > balance Sheet > cash
32128999
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
2375000
Quarters > 0 > balance Sheet > inventories
4869000
Quarters > 0 > balance Sheet > total Current Assets
42185000
Quarters > 0 > balance Sheet > property Plant Equipment
1324000
Quarters > 0 > balance Sheet > total Assets
117727000
Quarters > 0 > balance Sheet > payables
3469000
Quarters > 0 > balance Sheet > short Term Debt
442000
Quarters > 0 > balance Sheet > long Term Debt
30617000
Quarters > 0 > balance Sheet > total Liabilities
42793000
Quarters > 0 > balance Sheet > equity
74934000
Quarters > 0 > cash Flow > net Income
-2076752
Quarters > 0 > cash Flow > depreciation
547000
Quarters > 0 > cash Flow > change In Working Capital
-495000
Quarters > 0 > cash Flow > cash From Operations
-7350000
Quarters > 0 > cash Flow > capital Expenditures
41000
Quarters > 0 > cash Flow > cash From Investing
-41000
Quarters > 0 > cash Flow > cash From Financing
17393000
Quarters > 0 > cash Flow > net Change In Cash
9956999
Quarters > 0 > ratios > PE
-0.04184389059334731
Quarters > 0 > ratios > PB
7.875089860543946
Quarters > 0 > ratios > ROE
-2.771441535217658
Quarters > 0 > ratios > ROA
-1.7640405344568364
Quarters > 0 > ratios > FCF
-7391000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.4761334132214898
Quarters > 0 > health Score
22
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5369000
Quarters > 1 > income Statement > cost Of Revenue
1972000
Quarters > 1 > income Statement > gross Profit
3397000
Quarters > 1 > income Statement > operating Expenses
-5803000
Quarters > 1 > income Statement > operating Income
9200000
Quarters > 1 > income Statement > interest Expense
31000
Quarters > 1 > income Statement > pretax Income
-12990000
Quarters > 1 > income Statement > net Income
-12990000
Quarters > 1 > income Statement > eps
-0.26173184800476007
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
49630949
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-8398000
Quarters > 1 > income Statement > operating Margin
171.35406965915442
Quarters > 1 > income Statement > total Other Income Expense Net
-22190000
Quarters > 1 > balance Sheet > cash
21954000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
5389000
Quarters > 1 > balance Sheet > inventories
4609000
Quarters > 1 > balance Sheet > total Current Assets
32170000
Quarters > 1 > balance Sheet > property Plant Equipment
1471000
Quarters > 1 > balance Sheet > total Assets
108325000
Quarters > 1 > balance Sheet > payables
3379000
Quarters > 1 > balance Sheet > short Term Debt
510000
Quarters > 1 > balance Sheet > long Term Debt
30499000
Quarters > 1 > balance Sheet > total Liabilities
44339000
Quarters > 1 > balance Sheet > equity
63986000
Quarters > 1 > cash Flow > net Income
-12990000
Quarters > 1 > cash Flow > depreciation
802000
Quarters > 1 > cash Flow > change In Working Capital
1486000
Quarters > 1 > cash Flow > cash From Operations
-6031000
Quarters > 1 > cash Flow > capital Expenditures
44000
Quarters > 1 > cash Flow > cash From Investing
-44000
Quarters > 1 > cash Flow > cash From Financing
124000
Quarters > 1 > cash Flow > net Change In Cash
-5900000
Quarters > 1 > ratios > PE
-0.26173184800476007
Quarters > 1 > ratios > PB
9.222517169537088
Quarters > 1 > ratios > ROE
-20.301315912855937
Quarters > 1 > ratios > ROA
-11.991691668589892
Quarters > 1 > ratios > FCF
-6075000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.1314956230210467
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
6752000
Quarters > 2 > income Statement > cost Of Revenue
2870000
Quarters > 2 > income Statement > gross Profit
3882000
Quarters > 2 > income Statement > operating Expenses
-5527000
Quarters > 2 > income Statement > operating Income
9409000
Quarters > 2 > income Statement > interest Expense
34000
Quarters > 2 > income Statement > pretax Income
-9205000
Quarters > 2 > income Statement > net Income
-9227000
Quarters > 2 > income Statement > eps
-0.13734005286944556
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
67183606
Quarters > 2 > income Statement > income Tax Expense
22000
Quarters > 2 > income Statement > EBITDA
-8153000
Quarters > 2 > income Statement > operating Margin
139.35130331753552
Quarters > 2 > income Statement > total Other Income Expense Net
-18614000
Quarters > 2 > balance Sheet > cash
27854000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
5894000
Quarters > 2 > balance Sheet > inventories
4622000
Quarters > 2 > balance Sheet > total Current Assets
38562000
Quarters > 2 > balance Sheet > property Plant Equipment
1601000
Quarters > 2 > balance Sheet > total Assets
115600000
Quarters > 2 > balance Sheet > payables
2745000
Quarters > 2 > balance Sheet > short Term Debt
10785000
Quarters > 2 > balance Sheet > long Term Debt
18899000
Quarters > 2 > balance Sheet > total Liabilities
41901000
Quarters > 2 > balance Sheet > equity
73699000
Quarters > 2 > cash Flow > net Income
-9227000
Quarters > 2 > cash Flow > depreciation
1256000
Quarters > 2 > cash Flow > change In Working Capital
-902000
Quarters > 2 > cash Flow > cash From Operations
-6673000
Quarters > 2 > cash Flow > capital Expenditures
31000
Quarters > 2 > cash Flow > cash From Investing
-31000
Quarters > 2 > cash Flow > cash From Financing
6815000
Quarters > 2 > cash Flow > net Change In Cash
90000
Quarters > 2 > ratios > PE
-0.13734005286944556
Quarters > 2 > ratios > PB
10.838859080041793
Quarters > 2 > ratios > ROE
-12.51984423126501
Quarters > 2 > ratios > ROA
-7.981833910034602
Quarters > 2 > ratios > FCF
-6704000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.9928909952606635
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7604000
Quarters > 3 > income Statement > cost Of Revenue
2114000
Quarters > 3 > income Statement > gross Profit
5490000
Quarters > 3 > income Statement > operating Expenses
-6178000
Quarters > 3 > income Statement > operating Income
11668000
Quarters > 3 > income Statement > interest Expense
22000
Quarters > 3 > income Statement > pretax Income
-9477000
Quarters > 3 > income Statement > net Income
-9632000
Quarters > 3 > income Statement > eps
-0.23831307791756431
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
40417421
Quarters > 3 > income Statement > income Tax Expense
155000
Quarters > 3 > income Statement > EBITDA
-8382000
Quarters > 3 > income Statement > operating Margin
153.44555497106788
Quarters > 3 > income Statement > total Other Income Expense Net
-21145000
Quarters > 3 > balance Sheet > cash
27764000
Quarters > 3 > balance Sheet > short Term Investments
697000
Quarters > 3 > balance Sheet > receivables
5352000
Quarters > 3 > balance Sheet > inventories
4753000
Quarters > 3 > balance Sheet > total Current Assets
40529000
Quarters > 3 > balance Sheet > property Plant Equipment
1774000
Quarters > 3 > balance Sheet > total Assets
118884000
Quarters > 3 > balance Sheet > payables
3045000
Quarters > 3 > balance Sheet > short Term Debt
5955000
Quarters > 3 > balance Sheet > long Term Debt
23472000
Quarters > 3 > balance Sheet > total Liabilities
46865000
Quarters > 3 > balance Sheet > equity
72019000
Quarters > 3 > cash Flow > net Income
-9632000
Quarters > 3 > cash Flow > depreciation
2135000
Quarters > 3 > cash Flow > change In Working Capital
1904000
Quarters > 3 > cash Flow > cash From Operations
-6732000
Quarters > 3 > cash Flow > capital Expenditures
21000
Quarters > 3 > cash Flow > cash From Investing
-21000
Quarters > 3 > cash Flow > cash From Financing
18325000
Quarters > 3 > cash Flow > net Change In Cash
11554000
Quarters > 3 > ratios > PE
-0.23831307791756431
Quarters > 3 > ratios > PB
6.672727137144365
Quarters > 3 > ratios > ROE
-13.37424846221136
Quarters > 3 > ratios > ROA
-8.102015409979476
Quarters > 3 > ratios > FCF
-6753000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.8880852183061546
Quarters > 3 > health Score
23
Valuation > metrics > PE
-0.04184389059334731
Valuation > metrics > PB
7.875089860543946
Valuation > final Score
20
Valuation > verdict
162.5% Overvalued
Profitability > metrics > ROE
-2.771441535217658
Profitability > metrics > ROA
-4.9229631385563595
Profitability > metrics > Net Margin
-0.4147697223886559
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5710758801078282
Risk > metrics > Interest Coverage
-7.996627318718381
Risk > final Score
16
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.7862439273843
Liquidity > metrics > Quick Ratio
9.541293786755306
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:24:04.574Z
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADRIO Stock Analysis and Forecast - Earnings Growth Patterns & Fast Profit Portfolio Plans earlytimes.in
Read more →DarioHealth (NASDAQ:DRIO) Downgraded to Sell Rating by Wall Street Zen MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$18.25
Analyst Picks
Strong Buy
3
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 16.11% of the total shares of DarioHealth Corp
1.
Nantahala Capital Management, LLC(3.5259%)
since
2025/06/30
2.
Appian WAY Asset Management(2.6687%)
since
2025/06/30
3.
Phoenix Financial Ltd(2.3475%)
since
2025/06/30
4.
Y.D. More Investments Ltd(1.3621%)
since
2025/06/30
5.
Lasry Marc(0.9686%)
since
2025/06/30
6.
Vanguard Group Inc(0.7577%)
since
2025/06/30
7.
Geode Capital Management, LLC(0.7466%)
since
2025/06/30
8.
Vanguard Institutional Extnd Mkt Idx Tr(0.7162%)
since
2025/07/31
9.
AMH Equity Ltd(0.4479%)
since
2025/06/30
10.
Fidelity Extended Market Index(0.3929%)
since
2025/07/31
11.
Renaissance Technologies Corp(0.2704%)
since
2025/06/30
12.
LPL Financial Corp(0.2667%)
since
2025/06/30
13.
State Street Corp(0.1562%)
since
2025/06/30
14.
Fidelity Total Market Index(0.1316%)
since
2025/07/31
15.
XTX Topco Ltd(0.1302%)
since
2025/06/30
16.
Northern Trust Corp(0.1281%)
since
2025/06/30
17.
BlackRock Inc(0.1033%)
since
2025/06/30
18.
UBS Group AG(0.0997%)
since
2025/06/30
19.
Fidelity Series Total Market Index(0.0971%)
since
2025/07/31
20.
Spartan Extended Market Index Pool F(0.0869%)
since
2025/07/31
21.
NT Ext Equity Mkt Idx Fd - L(0.0863%)
since
2025/06/30
22.
Northern Trust Extended Eq Market Idx(0.0863%)
since
2025/06/30
23.
Extended Equity Market Fund K(0.0682%)
since
2025/06/30
24.
Wealth Enhancement Advisory Services, LLC(0.0589%)
since
2025/06/30
25.
Clarity Capital Partners LLC(0.0589%)
since
2025/06/30
26.
The Colony Group LLC(0.0501%)
since
2025/06/30
27.
Spartan Total Market Index Pool G(0.0453%)
since
2025/07/31
28.
Marco Investment Management LLC(0.0401%)
since
2025/06/30
29.
Tower Research Capital LLC(0.0396%)
since
2025/06/30
30.
NT Ext Equity Mkt Idx Fd - NL(0.0379%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0294%)
since
2025/06/30
32.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0243%)
since
2025/06/30
33.
Blackrock US Eq Mkt Fund CF(0.0187%)
since
2025/07/31
34.
Vanguard U.S. Eq Idx £ Acc(0.0168%)
since
2025/07/31
35.
U.S. Equity Market Fund F(0.0161%)
since
2025/06/30
36.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0117%)
since
2024/12/31
37.
Extended Equity Market Fund M(0.0086%)
since
2025/06/30
38.
Northern Trust Wilshire 5000(0.004%)
since
2025/06/30
39.
BNYM Mellon SL Market Completion UC1(0.0037%)
since
2025/06/30
40.
SSgA U.S. Total Market Index Strategy(0.0031%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.